Early Access Program With MaaT013 in Steroid-refractory Acute Gastrointestinal Graft Versus Host Disease

NCT04768907 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Acute Graft Versus Host Disease in Intestine
Steroid Refractory GVHD

Interventions

DRUG: MaaT013

Sponsor

MaaT Pharma